Objectives: Accurate assessment of cartilage status is increasingly becoming important to clinicians for offering joint preservation surgeries versus joint replacements. The goal of this study was to evaluate the validity of three-dimensional (3D), gradient-echo (GRE)-based T2* and T1Gd mapping for the assessment of various histological severities of degeneration in knee joint cartilage with potential implications for clinical management.
Methods: MRI and histological assessment were conducted in 36 ex vivo lateral femoral condyle specimens. The MRI protocol included a 3D GRE multiecho data image combination sequence in order to assess the T2* decay, a 3D double-echo steady-state sequence for assessment of cartilage morphology, and a dual flip angle 3D GRE sequence with volumetric interpolated breathhold examination for the T1Gd assessment. The histological sample analysis was performed according to the Mankin system. The data were then analysed statistically and correlated.
Results: We observed a significant decrease in the T2* and T1Gd values with increasing grades of cartilage degeneration (p<0.001) and a moderate correlation between T2* (r=0.514)/T1Gd (r=0.556) and the histological grading of cartilage degeneration (p<0.001). In addition, we noted a zonal variation in the T2* and T1Gd values reflecting characteristic zonal differences in the biochemical composition of hyaline cartilage.
Conclusions: This study outlines the potential of GRE-based T2* and T1Gd mapping to identify various grades of cartilage damage. Early changes in specific zones may assist clinicians in identifying methods of early intervention involving the targeted joint preservation approach versus moving forward with unicompartmental, bicompartmental or tricompartmental joint replacement procedures.
Trial Registration Number: DRKS00000729.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322206 | PMC |
| http://dx.doi.org/10.1136/bmjopen-2014-006895 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Automated pediatric brain tumor imaging assessment tool from CBTN: Enhancing suprasellar region inclusion and managing limited data with deep learning.
Neurooncol Adv
December 2024
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Background: Fully automatic skull-stripping and tumor segmentation are crucial for monitoring pediatric brain tumors (PBT). Current methods, however, often lack generalizability, particularly for rare tumors in the sellar/suprasellar regions and when applied to real-world clinical data in limited data scenarios. To address these challenges, we propose AI-driven techniques for skull-stripping and tumor segmentation.
View Article and Find Full Text PDFDual vision Transformer-DSUNET with feature fusion for brain tumor segmentation.
Heliyon
September 2024
Department of Information Systems, College of Computer and Information Sciences, King Saud University, Riyadh 11543, Saudi Arabia.
Brain tumors are one of the leading causes of cancer death; screening early is the best strategy to diagnose and treat brain tumors. Magnetic Resonance Imaging (MRI) is extensively utilized for brain tumor diagnosis; nevertheless, achieving improved accuracy and performance, a critical challenge in most of the previously reported automated medical diagnostics, is a complex problem. The study introduces the Dual Vision Transformer-DSUNET model, which incorporates feature fusion techniques to provide precise and efficient differentiation between brain tumors and other brain regions by leveraging multi-modal MRI data.
View Article and Find Full Text PDFOptimizing Glioblastoma, IDH-wildtype Treatment Outcomes : A Radiomics and Support Vector Machine-Based Approach to Overall Survival Estimation.
J Korean Neurosurg Soc
January 2025
Department of Neurosurgery, Taipei Medical University Hospital, Taipei, Taiwan.
Objective: Glioblastoma multiforme (GBM), particularly the isocitrate dehydrogenase (IDH)-wildtype type, represents a significant clinical challenge due to its aggressive nature and poor prognosis. Despite advancements in medical imaging and its modalities, survival rates have not improved significantly, demanding innovative treatment planning and outcome prediction approaches.
Methods: This study utilizes a support vector machine (SVM) classifier using radiomics features to predict the overall survival (OS) of GBM, IDH-wildtype patients to short (<12 months) and long (≥12 months) survivors.
Fully automatic mpMRI analysis using deep learning predicts peritumoral glioblastoma infiltration and subsequent recurrence.
Proc SPIE Int Soc Opt Eng
February 2024
Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA 19104.
Article Synopsis
- Glioblastoma (GBM) is a really aggressive brain tumor that's common in adults and hard to treat because it spreads into healthy brain tissue.
- Traditional treatments involve surgery, radiation, and chemotherapy, but they often don't work well since the tumor can infiltrate areas that are hard to see on scans.
- A new study uses advanced technology, specifically deep learning and MRI scans, to automatically create better maps of where the tumor might spread, helping doctors make better predictions about the disease.
CDPNet: a radiomic feature learning method with epigenetic application to estimating MGMT promoter methylation status in glioblastoma.
Proc SPIE Int Soc Opt Eng
February 2024
Center for Biomedical Image Computing and Analytics, University of Pennsylvania, 3700 Hamilton Walk, Philadelphia, PA, 19104, USA.
Radiomics has been widely recognized for its effectiveness in decoding tumor phenotypes through the extraction of quantitative imaging features. However, the robustness of radiomic methods to estimate clinically relevant biomarkers non-invasively remains largely untested. In this study, we propose Cascaded Data Processing Network (CDPNet), a radiomic feature learning method to predict tumor molecular status from medical images.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!